Literature DB >> 24650276

Corticosteroids are associated with repression of adaptive immunity gene programs in pediatric septic shock.

Hector R Wong1, Natalie Z Cvijanovich, Geoffrey L Allen, Neal J Thomas, Robert J Freishtat, Nick Anas, Keith Meyer, Paul A Checchia, Scott L Weiss, Thomas P Shanley, Michael T Bigham, Sharon Banschbach, Eileen Beckman, Kelli Harmon, Jerry J Zimmerman.   

Abstract

RATIONALE: Corticosteroids are prescribed commonly for patients with septic shock, but their use remains controversial and concerns remain regarding side effects.
OBJECTIVES: To determine the effect of adjunctive corticosteroids on the genomic response of pediatric septic shock.
METHODS: We retrospectively analyzed an existing transcriptomic database of pediatric septic shock. Subjects receiving any formulation of systemic corticosteroids at the time of blood draw for microarray analysis were classified in the septic shock corticosteroid group. We compared normal control subjects (n = 52), a septic shock no corticosteroid group (n = 110), and a septic shock corticosteroid group (n = 70) using analysis of variance. Genes differentially regulated between the no corticosteroid group and the corticosteroid group were analyzed using Ingenuity Pathway Analysis.
MEASUREMENTS AND MAIN RESULTS: The two study groups did not differ with respect to illness severity, organ failure burden, mortality, or mortality risk. There were 319 gene probes differentially regulated between the no corticosteroid group and the corticosteroid group. These genes corresponded predominately to adaptive immunity-related signaling pathways, and were down-regulated relative to control subjects. Notably, the degree of down-regulation was significantly greater in the corticosteroid group, compared with the no corticosteroid group. A similar pattern was observed for genes corresponding to the glucocorticoid receptor signaling pathway.
CONCLUSIONS: Administration of corticosteroids in pediatric septic shock is associated with additional repression of genes corresponding to adaptive immunity. These data should be taken into account when considering the benefit to risk ratio of adjunctive corticosteroids for septic shock.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24650276      PMCID: PMC4098101          DOI: 10.1164/rccm.201401-0171OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  36 in total

1.  The Pediatric Risk of Mortality III--Acute Physiology Score (PRISM III-APS): a method of assessing physiologic instability for pediatric intensive care unit patients.

Authors:  M M Pollack; K M Patel; U E Ruttimann
Journal:  J Pediatr       Date:  1997-10       Impact factor: 4.406

2.  Toward a clinically feasible gene expression-based subclassification strategy for septic shock: proof of concept.

Authors:  Hector R Wong; Derek S Wheeler; Ken Tegtmeyer; Sue E Poynter; Jennifer M Kaplan; Ranjit S Chima; Erika Stalets; Rajit K Basu; Lesley A Doughty
Journal:  Crit Care Med       Date:  2010-10       Impact factor: 7.598

Review 3.  A history of adjunctive glucocorticoid treatment for pediatric sepsis: moving beyond steroid pulp fiction toward evidence-based medicine.

Authors:  Jerry J Zimmerman
Journal:  Pediatr Crit Care Med       Date:  2007-11       Impact factor: 3.624

4.  Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock.

Authors:  Hector R Wong; Natalie Cvijanovich; Derek S Wheeler; Michael T Bigham; Marie Monaco; Kelli Odoms; William L Macias; Mark D Williams
Journal:  Am J Respir Crit Care Med       Date:  2008-05-29       Impact factor: 21.405

5.  Validating the genomic signature of pediatric septic shock.

Authors:  Natalie Cvijanovich; Thomas P Shanley; Richard Lin; Geoffrey L Allen; Neal J Thomas; Paul Checchia; Nick Anas; Robert J Freishtat; Marie Monaco; Kelli Odoms; Bhuvaneswari Sakthivel; Hector R Wong
Journal:  Physiol Genomics       Date:  2008-05-06       Impact factor: 3.107

6.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

7.  Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock.

Authors:  Thomas P Shanley; Natalie Cvijanovich; Richard Lin; Geoffrey L Allen; Neal J Thomas; Allan Doctor; Meena Kalyanaraman; Nancy M Tofil; Scott Penfil; Marie Monaco; Kelli Odoms; Michael Barnes; Bhuvaneswari Sakthivel; Bruce J Aronow; Hector R Wong
Journal:  Mol Med       Date:  2007 Sep-Oct       Impact factor: 6.354

8.  The pediatric sepsis biomarker risk model.

Authors:  Hector R Wong; Shelia Salisbury; Qiang Xiao; Natalie Z Cvijanovich; Mark Hall; Geoffrey L Allen; Neal J Thomas; Robert J Freishtat; Nick Anas; Keith Meyer; Paul A Checchia; Richard Lin; Thomas P Shanley; Michael T Bigham; Anita Sen; Jeffrey Nowak; Michael Quasney; Jared W Henricksen; Arun Chopra; Sharon Banschbach; Eileen Beckman; Kelli Harmon; Patrick Lahni; Christopher J Lindsell
Journal:  Crit Care       Date:  2012-10-01       Impact factor: 9.097

9.  Corticosteroids for severe sepsis: an evidence-based guide for physicians.

Authors:  Djillali Annane
Journal:  Ann Intensive Care       Date:  2011-04-13       Impact factor: 6.925

10.  A survey of Canadian intensivists' resuscitation practices in early septic shock.

Authors:  Lauralyn A McIntyre; Paul C Hébert; Dean Fergusson; Deborah J Cook; Ashique Aziz
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  31 in total

1.  A Common Genetic Variant in TLR1 Enhances Human Neutrophil Priming and Impacts Length of Intensive Care Stay in Pediatric Sepsis.

Authors:  Laura C Whitmore; Jessica S Hook; Amanda R Philiph; Brieanna M Hilkin; Xinyu Bing; Chul Ahn; Hector R Wong; Polly J Ferguson; Jessica G Moreland
Journal:  J Immunol       Date:  2016-01-04       Impact factor: 5.422

2.  Olfactomedin-4 Is a Candidate Marker for a Pathogenic Neutrophil Subset in Septic Shock.

Authors:  Matthew N Alder; Amy M Opoka; Patrick Lahni; David A Hildeman; Hector R Wong
Journal:  Crit Care Med       Date:  2017-04       Impact factor: 7.598

3.  Combining Prognostic and Predictive Enrichment Strategies to Identify Children With Septic Shock Responsive to Corticosteroids.

Authors:  Hector R Wong; Sarah J Atkinson; Natalie Z Cvijanovich; Nick Anas; Geoffrey L Allen; Neal J Thomas; Michael T Bigham; Scott L Weiss; Julie C Fitzgerald; Paul A Checchia; Keith Meyer; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J Freishtat; Jeffrey Nowak; Shekhar S Raj; Shira Gertz; Christopher J Lindsell
Journal:  Crit Care Med       Date:  2016-10       Impact factor: 7.598

4.  A Randomized Controlled Trial of Corticosteroids in Pediatric Septic Shock: A Pilot Feasibility Study.

Authors:  Kusum Menon; Dayre McNally; Katharine O'Hearn; Anand Acharya; Hector R Wong; Margaret Lawson; Tim Ramsay; Lauralyn McIntyre; Elaine Gilfoyle; Marisa Tucci; David Wensley; Ronald Gottesman; Gavin Morrison; Karen Choong
Journal:  Pediatr Crit Care Med       Date:  2017-06       Impact factor: 3.624

Review 5.  2016 Update for the Rogers' Textbook of Pediatric Intensive Care: Recognition and Initial Management of Shock.

Authors:  Julie C Fitzgerald; Scott L Weiss; Niranjan Kissoon
Journal:  Pediatr Crit Care Med       Date:  2016-11       Impact factor: 3.624

6.  Corticosteroids in Pediatric Septic Shock Are Not Helpful.

Authors:  Jerry J Zimmerman
Journal:  Crit Care Med       Date:  2018-04       Impact factor: 7.598

Review 7.  Pediatric Multiple Organ Dysfunction Syndrome: Promising Therapies.

Authors:  Allan Doctor; Jerry Zimmerman; Michael Agus; Surender Rajasekaran; Juliane Bubeck Wardenburg; James Fortenberry; Anne Zajicek; Emma Mairson; Katri Typpo
Journal:  Pediatr Crit Care Med       Date:  2017-03       Impact factor: 3.624

8.  It's About Time ….

Authors:  Jerry J Zimmerman
Journal:  Pediatr Crit Care Med       Date:  2015-10       Impact factor: 3.624

9.  Developing a clinically feasible personalized medicine approach to pediatric septic shock.

Authors:  Hector R Wong; Natalie Z Cvijanovich; Nick Anas; Geoffrey L Allen; Neal J Thomas; Michael T Bigham; Scott L Weiss; Julie Fitzgerald; Paul A Checchia; Keith Meyer; Thomas P Shanley; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J Freishtat; Jeffrey Nowak; Raj S Shekhar; Shira Gertz; Emily Dawson; Kelli Howard; Kelli Harmon; Eileen Beckman; Erin Frank; Christopher J Lindsell
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

10.  Corticosteroids in Pediatric Shock: A Call to Arms.

Authors:  Kusum Menon; Hector R Wong
Journal:  Pediatr Crit Care Med       Date:  2015-10       Impact factor: 3.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.